A US Food and Drug Administration (FDA) advisory panel has voted to ease restrictions on certain peptides, such as BPC-157, TB-500, and KPV, which have gained popularity online despite limited research on their effects in humans. These peptides, small proteins naturally produced by the body, are often marketed for unproven benefits like muscle building and skin improvement, especially among young influencers on platforms like TikTok. The panel’s decision could allow specialized pharmacies to produce these peptides for prescription use, although the FDA is not obligated to follow the panel’s recommendation. Health experts warn against their use due to the lack of clinical trials and unknown long-term effects. BPC-157, in particular, is popular for claims of aiding gut health and tissue repair but is banned in sports by the World Anti-Doping Agency. Despite being widely available online, these peptides are not approved for human use and lack the quality controls of pharmaceutical manufacturing.
QUESTION: How might the increased availability of peptides through prescriptions impact the wellness industry and public health?
US health panel loosens restrictions for controversial peptides popular online
